Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics ...
Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
Nature19 小时
Stealth particles give mucus the slip
We now know that most proteins diffuse easily through mucus ... To examine the effect of PEG surface attachment on particle diffusion, Wang and colleagues used a microscopy technique called ...